DCM Shriram Limited has informed the Exchange regarding 'Attaching File in Machine Readable Format'.
DCMSHRIRAM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
DCM Shriram's board, at its meeting on May 5, 2025, approved audited standalone and consolidated financial results for Q4 and FY ended March 31, 2025, with auditors Deloitte Haskins & Sells issuing an unmodified opinion. On a standalone basis, full-year FY25 revenue from operations rose to Rs. 12,441.96 crore (vs Rs. 11,170.89 crore in FY24), profit after tax jumped to Rs. 566.53 crore (vs Rs. 426.25 crore), and EBIDTA grew to Rs. 1,409.85 crore; FY25 EPS stood at Rs. 36.33 versus Rs. 27.33 a year earlier. The board recommended a final dividend of 170% (Rs. 3.40 per share), taking total FY25 dividend to 450% or Rs. 9 per share, subject to shareholder approval at the 36th AGM on August 12, 2025, with record date set as August 5, 2025. The board also approved the re-appointment of Mr. Ajit S. Shriram as Joint Managing Director for 5 years from May 2, 2026, continuation of Justice (Retd.) Vikramajit Sen as Independent Director post turning 75, and appointed M/s RMG & Associates as Secretarial Auditors for 5 years. Additionally, the company signed a binding agreement on May 4, 2025 to acquire a 53% stake in DNV Global Private Limited, making it a subsidiary, and commissioned new projects including a 12 TPD biogas plant and a 300 TPD caustic soda flaker plant.
Strong earnings growth (PAT up ~33% YoY) along with a healthy dividend payout and a fresh acquisition signals positive momentum; retail shareholders benefit from higher total dividend income and a potentially value-accretive expansion, likely to be viewed favorably by the market subject to execution on the DNV Global deal.